Related Experiment Videos
Abdominal pain in pediatric immunoglobulin A vasculitis: Risk factors and severity predictors in a multicenter cohort
Francisco Hugo Rodrigues Gomes1, Natalia Maronese1, Leticia Lizardo Magalhaes1
1Division of Pediatric Rheumatology, Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Insights
In pediatric immunoglobulin A vasculitis (IgAV), prolonged rash and high white blood cell count are linked to severe abdominal pain. Leukocytosis can predict acute abdomen in children with IgAV.
Area of Science:
- Pediatric Rheumatology
- Vasculitis Research
- Gastrointestinal Manifestations in Children
Background:
- Abdominal pain is a common complication in pediatric immunoglobulin A vasculitis (IgAV).
- Identifying risk factors for severe abdominal pain and its complications is crucial for timely intervention.
- Predicting which children with IgAV are at higher risk for complicated abdominal pain remains a clinical challenge.
Purpose of the Study:
- To determine risk factors for abdominal pain in pediatric IgAV patients.
- To identify predictors of complicated abdominal pain, including intussusception, intestinal bleeding, or acute abdomen.
- To evaluate the association of clinical factors with abdominal pain outcomes in IgAV.
Main Methods:
- Retrospective multicenter study of pediatric IgAV patients (≤18 years) meeting EULAR/PRINTO/PRES criteria.
- Analysis of factors associated with abdominal pain and complicated abdominal pain within the first 3 months and at the end of follow-up.
- Utilized univariate analyses, multivariable log-binomial regression, and receiver operating characteristic (ROC) curve analysis.
Main Results:
- 61.1% of 687 pediatric IgAV patients experienced abdominal pain within 3 months; 22.2% of those with pain developed complications.
- Prolonged purpuric/petechial rash (>29 days) and leukocytosis (>13,500/mm³ ) were independently associated with complicated abdominal pain.
- Leukocytosis demonstrated strong discriminatory performance for predicting acute abdomen (AUC 0.813).
Conclusions:
- Prolonged purpuric/petechial rash and leukocytosis are significant independent predictors of complicated abdominal pain in pediatric IgAV.
- Leukocytosis serves as a valuable clinical marker to identify children with IgAV at increased risk for developing acute abdomen.
- Early identification of these risk factors can guide management strategies for pediatric IgAV patients presenting with abdominal pain.
Objectives:
To identify risk factors for abdominal pain and predictors of complicated abdominal pain in pediatric immunoglobulin A vasculitis (IgAV).
Methods:
Retrospective multicenter study including children and adolescents (≤18 years) fulfilling the European League Against Rheumatism/Pediatric Rheumatology International Trials Organization/Pediatric Rheumatology European Society (EULAR/PRINTO/PRES) criteria for IgAV and followed at four tertiary centers in Brazil. Factors associated with abdominal pain in the overall cohort and with complicated abdominal pain (defined as abdominal pain associated with intussusception, intestinal bleeding, or acute abdomen) were evaluated during the first 3 months of the disease and at the end of follow-up. Univariate analyses, a pre-specified multivariable log-binomial regression model, and receiver operating characteristic (ROC) curve analysis were performed.
Results:
Among the 687 pediatric patients with IgAV, 420 (61.1%) developed abdominal pain within the first 3 months and 428 (62.3%) by the end of follow-up (median follow-up of 54.1 months [interquartile range 50.7-59.3]). Among patients with abdominal pain, 22.2% developed complications. Prolonged purpuric/petechial rash (>29 days; RRadj 1.78, 95% confidence interval [CI] 1.09-2.91) and leukocytosis (>13,500/mm3; RRadj 2.30, 95% CI 1.41-3.73) were independently associated with complications. Leukocytosis showed good discriminatory performance for predicting acute abdomen (area under the curve 0.813, 95% CI 0.704-0.923).
Conclusion:
Prolonged purpuric/petechial rash and leukocytosis were independently associated with complicated abdominal pain. Leukocytosis may help identify children at higher risk of acute abdomen.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Inflammatory Bowel Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...